Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.53 |
| ▸ | CTSB | P07858 | 1/20 | 0.53 |
| ▸ | YTHDC1 | Q96MU7 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.40 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.40 |
| ▸ | CDK2 | P24941 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | BRS3 | P32247 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | FLT3 | P36888 | 1/20 | 0.39 |
| ▸ | PDE5A | O76074 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2881233 | 0.82 | ADORA2A (0.50) | CTSLCTSBYTHDC1SMN1; SMN2ADORA3 | |
| SCHEMBL183730 | 0.77 | AXL (0.48) | ADORA3KMT2A | |
| SCHEMBL183221 | 0.76 | YTHDC1 (0.48) | YTHDC1SMN1; SMN2MAPK1HTTKMT2A | |
| SCHEMBL183167 | 0.75 | YTHDC1 (0.47) | YTHDC1SMN1; SMN2MAPK1HTTKMT2A | |
| SCHEMBL29601245 | 0.75 | YTHDC1 (0.47) | YTHDC1SMN1; SMN2MAPK1HTTKMT2A | |
| SCHEMBL16331916 | 0.72 | CTSL (0.61) | CTSLCTSBYTHDC1ADORA3FLT3 | |
| SCHEMBL7985354 | 0.70 | SMN1; SMN2 (0.43) | CTSLCTSBSMN1; SMN2KMT2ATSHR | |
| SCHEMBL15921507 | 0.69 | MDM2 (0.48) | CCNE1CDK2 | |
| SCHEMBL15921504 | 0.69 | MDM2 (0.48) | CCNE1CDK2 | |
| SCHEMBL17262783 | 0.69 | YTHDC1 (0.61) | CTSLCTSBYTHDC1ADORA3PDGFRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100152210-A1 | PURINYL DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | NEURO SEARCH A/S/ (DK) | 2010-06-17 | — | — | US | disclosed |
| US-20100152210-A1 | PURINYL DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | NEURO SEARCH A/S/ (DK) | 2010-06-17 | — | — | US | disclosed |
| US-20100152210-A1 | PURINYL DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | NEURO SEARCH A/S/ (DK) | 2010-06-17 | — | — | US | disclosed |
| WO-2008116911-A1 | PURINYL DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | NEUROSEARCH A/S (DK) | 2008-10-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152210-A1 | PURINYL DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | KCNJ2, KCNJ5, KCNJ3 | CTSL 4083/4885CTSB 4269/4885YTHDC1 3259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.